Source: Financial Modeling Prep · peers by sector/industry
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 3.1× sales vs its 4.0× historical median P/S.
Fair value ≈ $44.27 · price $35.00 today
Undervalued · 21% below
Loading valuation…
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$SIDU 🧠 SIDU vs EVBG – history doesn’t repeat, but it rhymes
Back in the day Everbridge ($EVBG) took heat for offerings + dilution.
Market cried foul… then execution took over.
📉 EVBG around $10–$15
📈 Ran to $160+ at the highs
Why?
✔️ Capital raises funded growth
✔️ Narrative flipped
✔️ Shorts trapped fighting strength
Now look at Sidus Space ($SIDU) 👀
– Back-to-back offerings
– Yet price keeps holding strength
– Float absorbed, not dumped
That’s not weakness… that’s demand.
If SIDU follows even a fraction of the EVBG playbook, $5+ is just a checkpoint, not the destination 🚀
we’ve seen this movie before 👀💥
$RKLB $SPCE $VTSI
$EVBG Everbridge, Inc. (NASDAQ:EVBG): Powering Resilience Through Intelligent Automation https://beyondspx.com/article/everbridge-inc-nasdaq-evbg-powering-resilience-through-intelligent-automation
$AU $BABA $EVBG $MDGL $NMRK he is marrying a 35yr old whore... his investing capsbility issupremely compromised.. i would do the opppsite of everyone of his trades right now
$EVBG $BABA $MDGL $AU $NMRK
Paulson buys Everbridge, cuts Anglogold in Q2
ohn Paulson's Paulson & Co. disclosed in an SEC filing its holdings as of June 30, 2024. The fund's one new buy during the second quarter was Everbridge (EVBG). The fund exited two positions during the quarter, namely Newmark (NMRK) and Alibaba (BABA). Paulson increased its stake in Madrigal Pharma (MDGL) and reduced its position in Anglogold (AU). The fund's top holdings as of June 30, in order of size, were Madrigal, Brightsphere (BSIG), Bausch Health (BHC), Perpetua (PPTA), and Novagold (NG).
